| Jun 2008 | 2007 | ||||||
|---|---|---|---|---|---|---|---|
| Total Revenues ($Mil): | 771.12 | 1.16 | |||||
| Depreciation & Amort ($Mil): | |||||||
| Operating Income ($Mil): | -28.75 | -33.72 | |||||
| Net Income ($Mil): | -56.59 | -53.11 | |||||
| Earnings Per Share ($): | -32.36 | -14.16 | |||||
| Dividends ($): | 0.00 | 0.00 |
| Jun 2008 | 2007 | ||||||
|---|---|---|---|---|---|---|---|
| Current Assets ($Mil): | 97.64 | 116.98 | |||||
| Current Liabilities ($Mil): | 9.78 | 9.30 | |||||
| Long Term Debt ($Mil): | 5.49 | 7.46 | |||||
| Shares Outstanding (000): | 22190 | 22180 | 0 | 0 | 0 | 0 | 0 |
| Common Equity ($Mil): | 95.05 | 112.35 |
| Jun 2008 | 2007 | ||||||
|---|---|---|---|---|---|---|---|
| Profit Margin (%): | -7.34 | -4578.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Equity (%): | -135.25 | -47.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Assets (%): | -56 | -41.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P/E Ratio: | 0 | -1.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price/Book: | 2 | 4.52 | NaN | NaN | NaN | NaN | NaN |
| Debt Equity: | 0.06 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage: | 0.00 | -25.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book Value ($): | 4.28 | 5.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price/Sales: | 179.93 | 0.18 | NaN | NaN | NaN | NaN | NaN |
| Dividend Payout (%): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |

| AMGEN | -15.10 | 48.58 | |
| GILEAD SCIENCES | -26.60 | 37.47 | |
| GENENTECH INC | -9.90 | 73.00 | |
| CELGENE CP | -26.70 | 54.52 | |
| BIOGEN IDEC INC | -34.90 | 42.78 |
